Boston Scientific Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,965	414	865	928	1,925
Cash & Short-Term Investments	1,965	414	865	928	1,925
Cash Growth	374.64%	-52.14%	-6.79%	-51.79%	11.02%
Accounts Receivable	2,926	2,558	2,228	1,970	1,778
Receivables	2,926	2,558	2,228	1,970	1,778
Inventory	2,943	2,810	2,484	1,867	1,610
Restricted Cash	80	111	130	149	188
Other Current Assets	880	1,027	807	846	816
Total Current Assets	8,794	6,920	6,514	5,760	6,317
Property, Plant & Equipment	4,501	3,743	3,298	2,832	2,687
Long-Term Investments	682	555	413	407	411
Goodwill	18,282	17,089	14,387	12,920	11,988
Other Intangible Assets	7,019	6,684	6,003	5,969	6,235
Long-Term Deferred Tax Assets	3,675	3,655	3,841	3,942	4,142
Other Long-Term Assets	720	749	680	639	449
Total Assets	43,673	39,395	35,136	32,469	32,229
Accounts Payable	1,144	960	942	862	794
Accrued Expenses	3,201	2,773	2,136	1,855	1,883
Current Portion of Long-Term Debt	299	1,778	531	20	261
Current Portion of Leases	90	81	76	61	71
Current Income Taxes Payable	-	-	220	232	209
Current Unearned Revenue	313	306	266	220	208
Other Current Liabilities	392	501	762	553	848
Total Current Liabilities	5,439	6,399	4,933	3,803	4,274
Long-Term Debt	11,012	8,842	8,566	8,910	8,798
Long-Term Leases	571	527	395	352	395
Long-Term Unearned Revenue	369	329	311	289	276
Long-Term Deferred Tax Liabilities	220	155	134	144	310
Other Long-Term Liabilities	1,590	1,140	1,267	1,398	1,554
Total Liabilities	19,201	17,392	15,606	14,896	15,607
Common Stock	17	17	17	17	17
Additional Paid-In Capital	21,505	21,056	20,647	20,289	19,986
Retained Earnings	5,571	2,673	819	-750	-1,392
Treasury Stock	-2,251	-2,251	-2,251	-2,251	-2,251
Comprehensive Income & Other	-609	275	50	268	262
Total Common Equity	24,233	21,770	19,282	17,573	16,622
Minority Interest	239	233	248	-	-
Shareholders' Equity	24,472	22,003	19,530	17,573	16,622
Total Liabilities & Equity	43,673	39,395	35,136	32,469	32,229
Total Debt	11,972	11,228	9,568	9,343	9,525
Net Cash (Debt)	-10,007	-10,814	-8,703	-8,415	-7,600
Net Cash Per Share	-6.70	-7.28	-5.95	-5.84	-5.30
Filing Date Shares Outstanding	1,484	1,476	1,467	1,435	1,427
Total Common Shares Outstanding	1,483	1,475	1,466	1,433	1,426
Working Capital	3,355	521	1,581	1,957	2,043
Book Value Per Share	16.34	14.76	13.16	12.26	11.66
Tangible Book Value	-1,068	-2,003	-1,108	-1,316	-1,601
Tangible Book Value Per Share	-0.72	-1.36	-0.76	-0.92	-1.12
Land	173	144	140	137	109
Buildings	2,485	2,018	1,843	1,695	1,523
Machinery	3,827	3,630	3,503	3,298	3,288
Construction In Progress	1,161	1,035	857	598	605

Source: S&P Global Market Intelligence. Standard template. Financial Sources.